03.31.25 -- The "One-and-Done" PI & Measuring The Current Site Landscape

As protocols and studies become more complex, using technology to offer sites in-depth expertise and guidance is more important than ever to launch studies on time.

Informed consent is essential in clinical research. However, when participants lose decisional capacity, a Legally Authorized Representative (LAR) is needed to provide consent and uphold ethical standards.

Delve into the significance of evolving clinical trial models, their potential to remove barriers to participation, and strategies for sponsors to implement hybrid and decentralized designs.

Reduce the administrative strain on sites and sponsors using a patient-first technology platform to streamline payments, travel coordination, tax management, and site-participant communication.

This "In Their Shoes" video shares LaToya Bolds-Johnson's journey with breast cancer and her advice to others going through similar struggles.

Learn how shifting policies create opportunities for the private sector to prioritize innovation in clinical trials for better healthcare.

Addressing immunological challenges and navigating the evolving regulatory environment is critical for its successful integration into clinical practice.

Through our SiteSelect model and Research Partner Services, we empower research sites to participate seamlessly in clinical trials, removing barriers to entry and enhancing site efficiency.